Nerve injury repair technology based on stem cells

Through stem cell-based nerve damage repair technology, three-dimensional scaffolds and neurotrophic factor support made of biocompatible materials are solved, and the effective growth and functional recovery of nerve cells are achieved.

CN118987356APending Publication Date: 2024-11-22SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410945662.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing three-dimensional stents may trigger immune responses or tissue rejection in nerve damage repair, affecting the therapeutic effect.

Method used

Using stem cell-based nerve injury repair technology, by selecting suitable stem cell sources, such as inducing pluripotent stem cells or adult stem cells, differentiating into nerve cells, and using a three-dimensional scaffold made of biocompatible materials, combined with the support of neurotrophic factors, Perform transplantation and monitoring to reduce immune response.

Benefits of technology

It improves the survival and function of nerve cells, enhances growth and differentiation after transplantation, reduces the rejection between three-dimensional scaffolds and human cells, and promotes the recovery of nerve function and tissue reconstruction.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987356A_ABST
    Figure CN118987356A_ABST
Patent Text Reader

Abstract

The invention discloses a nerve injury repair technology based on stem cells, which can realize that a three-dimensional scaffold is prepared by selecting a biocompatible material, the scaffold is arranged in a manner that large and small apertures are staggered, and the pore structure, the aperture size and the porosity of the scaffold influence the permeability of cells and the transmission of nutrient substances; the large aperture is beneficial to cell migration and angiogenesis, the small aperture is beneficial to cell attachment and differentiation, the bioactive molecules are coated on the surface of the stent, the cell attachment and growth speed can be enhanced, and the neurotrophic factors are coated to promote the survival and growth of nerve cells, so that the biological activity of the stent is improved. Molecules with an immunoregulation function, including transforming growth factors, are introduced to the stent, the transforming growth factors are wrapped in microspheres or nanoparticles, the microspheres or nanoparticles are degraded along with time, the thickness of the microspheres or nanoparticles can be adjusted according to the physical state of a patient, and the microspheres or nanoparticles are different in degradation duration and release amount according to different thicknesses. The method is used for regulating local immune response.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of nerve damage repair, and more specifically, to a nerve damage repair technology based on stem cells. Background Art

[0002] With the rapid development of stem cell research, stem cell-based nerve damage repair technology has gradually become a research hotspot in the field of neuroscience and regenerative medicine. Nerve damage, including spinal cord injury, brain injury, and various neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, are major challenges facing modern medicine. These diseases usually lead to severe disability or cognitive dysfunction, which greatly affects the quality of life of patients.

[0003] The human body's nervous tissue refers to the tissue system in the body that is responsible for transmitting nerve signals and controlling various physiological functions. These nervous tissues include the central nervous system and the peripheral nervous system. The nervous tissue plays an extremely important role in the human body, responsible for connecting and coordinating various parts of the body to ensure normal physiological and behavioral functions.

[0004] Three-dimensional scaffolds are needed in the treatment of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. Three-dimensional scaffolds are a type of bionic engineering material that can provide nerve cells with a three-dimensional structure similar to the in vivo environment, supporting cell growth, differentiation and functional recovery. However, there are still some challenges in the use of three-dimensional scaffolds. Implantation of three-dimensional scaffolds in the body may cause immune responses or tissue rejection, thereby affecting the treatment effect.

[0005] Therefore, in response to the above technical problems, it is necessary to provide a stem cell-based nerve damage repair technology. Summary of the invention

[0006] The purpose of the present invention is to provide a stem cell-based nerve damage repair technology to solve the above-mentioned problems.

[0007] In order to achieve the above purpose, the technical solution provided by an embodiment of the present invention is as follows:

[0008] A stem cell-based nerve damage repair technology comprises the following steps:

[0009] S1. Selection of stem cell sources: Choose appropriate stem cell sources, such as induced pluripotent stem cells or adult stem cells. Induced pluripotent stem cells can be obtained by reprogramming adult somatic cells, while adult stem cells can be isolated and expanded from adult tissues.

[0010] S2, Differentiate stem cells into neural cells, differentiate stem cells into neurons, astrocytes or other neural-related cell types in vitro through specific culture conditions and growth factors;

[0011] S3, stem cell repair transplantation, transplanting differentiated nerve cells into the damaged nerve tissue area;

[0012] S4. Neurotrophic factor support: In order to enhance the survival and function of transplanted nerve cells, neurotrophic factors such as brain-derived neurotrophic factor and neurotrophin 3 can be delivered simultaneously to promote nerve cell regeneration and the survival of surrounding neurons;

[0013] S5. Monitoring and evaluation: using imaging, electrophysiology, and behavioral techniques to monitor the recovery of neural function and reconstruction of tissue structure in the repaired area;

[0014] S6. Follow-up and long-term effect evaluation: Long-term tracking of patients to evaluate the safety and efficacy of stem cell transplantation and the sustained improvement of neurological function.

[0015] As a further improvement of the present invention, the adult stem cells in step S1 include neural stem cells and bone marrow stem cells.

[0016] As a further improvement of the present invention, in step S2, the culture medium required for differentiating stem cells into neural cells is a serum-free culture medium. In order to control the differentiation environment, a serum-free culture medium is often used to reduce the interference of exogenous factors, and poly-D-lysine and laminin are required as matrix materials to promote cell adhesion and growth.

[0017] As a further improvement of the present invention, the differentiation process of different stem cells in step S2 is:

[0018] S21, neuronal differentiation, basal growth factors and epidermal growth factor were added to the culture medium to expand neural stem cells, followed by the addition of retinoic acid to initiate neuronal differentiation, followed by the addition of brain-derived neurotrophic factor and neurotrophin 3 to promote neuronal maturation and functionalization;

[0019] S22, astrocyte differentiation, similar to neuronal differentiation, adds basal growth factor and epidermal growth factor to the culture medium to expand neural stem cells, and uses a culture medium containing ciliary neurotrophic factor and bone morphogenetic protein to promote the differentiation of neural stem cells into astrocytes;

[0020] S23. Oligodendrocyte differentiation: Similarly, basal growth factor and epidermal growth factor are added to the culture medium to expand neural stem cells, SHH and platelet-derived growth factor-AA are added to promote the differentiation of stem cells into oligodendrocytes, and then insulin-like growth factor can be added to support its maturation. SHH is an important signaling molecule.

[0021] As a further improvement of the present invention, in step S3, transplanting the differentiated neural cells to the damaged neural tissue area can be achieved in several different ways:

[0022] S31. Direct injection: This is the simplest and most direct method, which is to inject differentiated neural cells directly into the damaged neural tissue area. This method can be implemented quickly, but it is necessary to ensure that the injected cells can survive and effectively interact with the surrounding environment;

[0023] S32. Scaffold loading: Differentiated neural cells can be planted on a scaffold or carrier, and then the entire structure can be implanted into the damaged area. The scaffold can provide structural support and guidance to help neural cells colonize and grow in the correct location;

[0024] S33. Tissue engineering in three-dimensional scaffolds: Cultivating stem cells in three-dimensional scaffolds can create a more complex and structured neural tissue engineering. This approach can promote cell growth, differentiation and functional reconstruction by controlling the physical and chemical properties of the scaffold, helping to repair damaged neural tissue more effectively.

[0025] As a further improvement of the present invention, the three-dimensional scaffold is an artificial structure used to support cell growth, differentiation and tissue formation, and is usually made of biocompatible materials, which can mimic the physical and chemical properties of the extracellular matrix in the body. Commonly used biocompatible materials include natural polysaccharides and synthetic polymers, namely alginate, collagen and polylactic acid-hydroxybutyric acid copolymer, polycaprolactone. These materials should have good biocompatibility, degradability and appropriate mechanical strength. The pore structure, pore size and porosity of the scaffold affect the permeability of cells and the transfer of nutrients. The scaffold is arranged in a staggered manner with large and small pore sizes, and bioactive molecules are coated on the surface of the scaffold, which can enhance the adhesion and growth rate of cells. Coating with neurotrophic factors can promote the survival and growth of nerve cells.

[0026] As a further improvement of the present invention, the bioactive molecules include cell adhesion factors and growth factors, and the neurotrophic factors include nerve growth factor and brain-derived neurotrophic factor.

[0027] As a further improvement of the present invention, molecules with immunomodulatory function, including transforming growth factor, are introduced into the scaffold to regulate local immune response and reduce the rejection reaction between the three-dimensional scaffold and human cells.

[0028] As a further improvement of the present invention, in step S4, the implantation of neurotrophic factors can utilize biomaterials as carriers to control the release rate of the neurotrophic factors so that they can be released long-term and stably. The neurotrophic factors are encapsulated in hydrogels and gradually released after being implanted in the target area.

[0029] As a further improvement of the present invention, the neurotrophic factor encapsulated in the hydrogel can be implanted near the affected area while the three-dimensional scaffold is implanted in the affected area, and the pore structure of the hydrogel has an important influence on the release rate of the neurotrophic factor. By controlling the pore size and distribution of the hydrogel, the diffusion rate and release rate of the neurotrophic factor can be adjusted. Larger pores will lead to a faster release rate, while smaller pores will slow down the release rate. Compared with the prior art, the advantages of the present invention are:

[0030] This solution can achieve the goal of making a three-dimensional scaffold by selecting biocompatible materials, and the scaffold is arranged in a staggered manner with large and small pore sizes. The pore structure, pore size and porosity of the scaffold affect the permeability of cells and the transfer of nutrients. Larger pores are conducive to cell migration and angiogenesis, while smaller pores are conducive to cell attachment and differentiation. Coating the surface of the scaffold with bioactive molecules can enhance cell attachment and growth rate. Coating with neurotrophic factors can promote the survival and growth of nerve cells. Molecules with immunomodulatory functions, including transforming growth factor, are introduced into the scaffold. The transforming growth factor is encapsulated in microspheres or nanoparticles and degrades over time. The thickness of the microspheres or nanoparticles can be adjusted according to the patient's physical condition, and the degradation time and release amount are different according to the thickness, which is used to regulate local immune responses and reduce the rejection reaction of the three-dimensional scaffold and human cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 This is a flow chart of the nerve damage repair technology of the present invention. DETAILED DESCRIPTION

[0032] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention; it is obvious that the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments, and all other embodiments obtained by ordinary technicians in this field based on the embodiments of the present invention without making creative work are within the scope of protection of the present invention.

[0033] Embodiment 1:

[0034] See also Figure 1 , a stem cell-based nerve damage repair technology, comprising the following steps:

[0035] S1. Selection of stem cell sources: Choose appropriate stem cell sources, such as induced pluripotent stem cells or adult stem cells. Induced pluripotent stem cells can be obtained by reprogramming adult somatic cells, while adult stem cells can be isolated and expanded from adult tissues.

[0036] S2, Differentiate stem cells into neural cells, differentiate stem cells into neurons, astrocytes or other neural-related cell types in vitro through specific culture conditions and growth factors;

[0037] S3, stem cell repair transplantation, transplanting differentiated nerve cells into the damaged nerve tissue area;

[0038] S4. Neurotrophic factor support: In order to enhance the survival and function of transplanted nerve cells, neurotrophic factors such as brain-derived neurotrophic factor and neurotrophin 3 can be delivered simultaneously to promote nerve cell regeneration and the survival of surrounding neurons;

[0039] S5. Monitoring and evaluation: using imaging, electrophysiology, and behavioral techniques to monitor the recovery of neural function and reconstruction of tissue structure in the repaired area;

[0040] S6. Follow-up and long-term effect evaluation: Long-term tracking of patients to evaluate the safety and efficacy of stem cell transplantation and the sustained improvement of neurological function.

[0041] The adult stem cells in step S1 include neural stem cells and bone marrow stem cells.

[0042] In step S2, the culture medium required for differentiating stem cells into neural cells is a serum-free culture medium. In order to control the differentiation environment, a serum-free culture medium is often used to reduce the interference of exogenous factors, and poly-D-lysine and laminin are required as matrix materials to promote cell adhesion and growth.

[0043] Specifically, the differentiation of stem cells into neural cells is a complex process that requires specific culture conditions and factors to guide the cells to develop in the direction of neural cells. Serum-free culture medium is usually used to control the differentiation environment and reduce the interference of exogenous factors. Poly-D-lysine and laminin as matrix materials can promote cell adhesion and growth and provide cells with a suitable growth environment; serum-free culture medium usually does not contain exogenous factors such as fetal bovine serum or fetal bovine serum, avoiding the interference of these factors in the cell differentiation process. At the same time, by adding specific growth factors and cytokines, the differentiation direction of stem cells into neural cells can be precisely controlled. The above factors work together to provide stem cells with a suitable growth environment, which is conducive to their differentiation into neural cells. The use of poly-D-lysine and laminin as matrix materials in serum-free culture medium is to simulate the natural growth environment to the greatest extent possible to achieve effective differentiation of stem cells into neural cells.

[0044] The differentiation process of different stem cells in step S2 is:

[0045] S21, neuronal differentiation, basal growth factors and epidermal growth factor were added to the culture medium to expand neural stem cells, followed by the addition of retinoic acid to initiate neuronal differentiation, followed by the addition of brain-derived neurotrophic factor and neurotrophin 3 to promote neuronal maturation and functionalization;

[0046] S22, astrocyte differentiation, similar to neuronal differentiation, adds basal growth factor and epidermal growth factor to the culture medium to expand neural stem cells, and uses a culture medium containing ciliary neurotrophic factor and bone morphogenetic protein to promote the differentiation of neural stem cells into astrocytes;

[0047] S23. Oligodendrocyte differentiation: Similarly, basal growth factor and epidermal growth factor are added to the culture medium to expand neural stem cells, SHH and platelet-derived growth factor-AA are added to promote the differentiation of stem cells into oligodendrocytes, and then insulin-like growth factor can be added to support its maturation. SHH is an important signaling molecule.

[0048] Specifically, basal growth factor and epidermal growth factor are used to expand neural stem cells and lay the foundation for subsequent differentiation; retinoic acid is used to initiate the differentiation of neurons; brain-derived neurotrophic factor and neurotrophic factor 3 promote the maturation and functionalization of neurons, ciliary neurotrophic factor and bone morphogenetic protein induce neural stem cells to differentiate into astrocytes, SHH and PDGF-AA initiate the differentiation of oligodendrocytes, and insulin-like growth factor supports the maturation of oligodendrocytes; by precisely controlling these growth factors and conditions, stem cells can be effectively guided to differentiate into specific types of neural cells.

[0049] In step S3, transplanting the differentiated neural cells into the damaged neural tissue area can be achieved in several different ways:

[0050] S31. Direct injection: This is the simplest and most direct method, which is to inject differentiated neural cells directly into the damaged neural tissue area. This method can be implemented quickly, but it is necessary to ensure that the injected cells can survive and effectively interact with the surrounding environment;

[0051] S32. Scaffold loading: Differentiated neural cells can be planted on a scaffold or carrier, and then the entire structure can be implanted into the damaged area. The scaffold can provide structural support and guidance to help neural cells colonize and grow in the correct location;

[0052] S33. Tissue engineering in three-dimensional scaffolds: Cultivating stem cells in three-dimensional scaffolds can create a more complex and structured neural tissue engineering. This approach can promote cell growth, differentiation and functional reconstruction by controlling the physical and chemical properties of the scaffold, helping to repair damaged neural tissue more effectively.

[0053] Specifically, this method involves culturing stem cells in a three-dimensional scaffold to create a more complex and structured neural tissue engineering. By controlling the physical and chemical properties of the scaffold, cell growth, differentiation and functional reconstruction can be promoted, helping to more effectively repair damaged neural tissue.

[0054] Three-dimensional scaffolds are artificial structures used to support cell growth, differentiation and tissue formation. They are usually made of biocompatible materials and can mimic the physical and chemical properties of the extracellular matrix in the body. Commonly used biocompatible materials include natural polysaccharides and synthetic polymers, namely alginate, collagen, polylactic acid-hydroxybutyric acid copolymer, and polycaprolactone. These materials should have good biocompatibility, degradability, and appropriate mechanical strength. The pore structure, pore size, and porosity of the scaffold affect the permeability of cells and the delivery of nutrients. The scaffold is arranged in a staggered manner with large and small pores, and bioactive molecules are coated on the surface of the scaffold to enhance cell adhesion and growth rate. Coating with neurotrophic factors can promote the survival and growth of nerve cells.

[0055] Bioactive molecules include cell adhesion factors and growth factors, and neurotrophic factors include nerve growth factor and brain-derived neurotrophic factor;

[0056] Molecules with immunomodulatory functions, including transforming growth factor, are introduced into the scaffold to regulate local immune responses and reduce the rejection reaction between the three-dimensional scaffold and human cells. Microspheres or nanoparticles are prepared using biodegradable polymers, which encapsulate transforming growth factor and mix it into the scaffold material.

[0057] Specifically, the application of three-dimensional scaffolds in tissue engineering requires comprehensive consideration of the biocompatibility, degradability, mechanical strength and pore structure design of the materials. By coating the surface with bioactive molecules and introducing immunomodulatory functions, the functionality and cell friendliness of the scaffolds can be significantly improved, thereby promoting effective tissue regeneration and functional recovery. The introduction of molecules with immunomodulatory functions such as transforming growth factor can regulate local immune responses and reduce the rejection reaction between the scaffold and human cells. Microspheres or nanoparticles are prepared using biodegradable polymers, and transforming growth factors are encapsulated and mixed into the scaffold material to achieve sustained release and local immunomodulatory effects.

[0058] In step S4, the implantation of neurotrophic factors can utilize biomaterials as carriers to control the release rate of neurotrophic factors so that they can be released long-term and stably. The neurotrophic factors are encapsulated in hydrogels and gradually released after being implanted in the target area. The neurotrophic factors encapsulated in the hydrogels can be implanted near the affected area while the three-dimensional scaffold is implanted in the affected area. The pore structure of the hydrogel has an important influence on the release rate of the neurotrophic factors. By controlling the pore size and distribution of the hydrogel, the diffusion rate and release rate of the neurotrophic factors can be adjusted. Larger pores will lead to faster release rates, while smaller pores will slow down the release rate.

[0059] Specifically, by using hydrogel as a carrier of neurotrophic factors and precisely controlling its pore structure, we can achieve precise regulation of the release rate of neurotrophic factors.

[0060] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.

[0061] In addition, it should be understood that although the present specification is described according to embodiments, not every embodiment contains only one independent technical solution. This narrative method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation methods that those skilled in the art can understand.

Claims

1. A stem cell-based nerve damage repair technology, Features: The following steps are involved: S1. Selection of stem cell sources: Choose appropriate stem cell sources, such as induced pluripotent stem cells or adult stem cells. Induced pluripotent stem cells can be obtained by reprogramming adult somatic cells, while adult stem cells can be isolated and expanded from adult tissues. S2, Differentiate stem cells into neural cells, differentiate stem cells into neurons, astrocytes or other neural-related cell types in vitro through specific culture conditions and growth factors; S3, stem cell repair transplantation, transplanting differentiated nerve cells into the damaged nerve tissue area; S4. Neurotrophic factor support: In order to enhance the survival and function of transplanted nerve cells, neurotrophic factors such as brain-derived neurotrophic factor and neurotrophin 3 can be delivered simultaneously to promote nerve cell regeneration and the survival of surrounding neurons; S5. Monitoring and evaluation: using imaging, electrophysiology, and behavioral techniques to monitor the recovery of neural function and reconstruction of tissue structure in the repaired area; S6. Follow-up and long-term effect evaluation: Long-term tracking of patients to evaluate the safety and efficacy of stem cell transplantation and the sustained improvement of neurological function.

2. A stem cell-based nerve damage repair technology according to claim 1, Features: The adult stem cells in step S1 include neural stem cells and bone marrow stem cells.

3. A stem cell-based nerve damage repair technology according to claim 1, Features: In step S2, the culture medium required for differentiating stem cells into neural cells is a serum-free culture medium. In order to control the differentiation environment, a serum-free culture medium is often used to reduce the interference of exogenous factors, and poly-D-lysine and laminin are required as matrix materials to promote cell adhesion and growth.

4. A stem cell-based nerve damage repair technology according to claim 3, Features: The differentiation process of different stem cells in step S2 is: S21, neuronal differentiation, basal growth factors and epidermal growth factor were added to the culture medium to expand neural stem cells, followed by the addition of retinoic acid to initiate neuronal differentiation, followed by the addition of brain-derived neurotrophic factor and neurotrophin 3 to promote neuronal maturation and functionalization; S22, astrocyte differentiation, similar to neuronal differentiation, adds basal growth factor and epidermal growth factor to the culture medium to expand neural stem cells, and uses a culture medium containing ciliary neurotrophic factor and bone morphogenetic protein to promote the differentiation of neural stem cells into astrocytes; S23. Oligodendrocyte differentiation: Similarly, basal growth factor and epidermal growth factor are added to the culture medium to expand neural stem cells, SHH and platelet-derived growth factor-AA are added to promote the differentiation of stem cells into oligodendrocytes, and then insulin-like growth factor can be added to support its maturation. SHH is an important signaling molecule.

5. The stem cell-based nerve damage repair technology according to claim 1, Features: In step S3, transplanting the differentiated neural cells into the damaged neural tissue area can be achieved in several different ways: S31. Direct injection: This is the simplest and most direct method, which is to inject differentiated neural cells directly into the damaged neural tissue area. This method can be implemented quickly, but it is necessary to ensure that the injected cells can survive and effectively interact with the surrounding environment; S32. Scaffold loading: Differentiated neural cells can be planted on a scaffold or carrier, and then the entire structure can be implanted into the damaged area. The scaffold can provide structural support and guidance to help neural cells colonize and grow in the correct location; S33. Tissue engineering in three-dimensional scaffolds: Cultivating stem cells in three-dimensional scaffolds can create a more complex and structured neural tissue engineering. This approach can promote cell growth, differentiation and functional reconstruction by controlling the physical and chemical properties of the scaffold, helping to repair damaged neural tissue more effectively.

6. A stem cell-based nerve damage repair technology according to claim 5, Features: The three-dimensional scaffold is an artificial structure used to support cell growth, differentiation and tissue formation. It is usually made of biocompatible materials and can mimic the physical and chemical properties of the extracellular matrix in the body. Commonly used biocompatible materials include natural polysaccharides and synthetic polymers, namely alginate, collagen, polylactic acid-hydroxybutyric acid copolymer, and polycaprolactone. These materials should have good biocompatibility, degradability, and appropriate mechanical strength. The pore structure, pore size, and porosity of the scaffold affect the permeability of cells and the delivery of nutrients. The scaffold is arranged in a staggered manner with large and small pore sizes, and bioactive molecules are coated on the surface of the scaffold, which can enhance the adhesion and growth rate of cells. Coating with neurotrophic factors can promote the survival and growth of nerve cells.

7. A stem cell-based nerve damage repair technology according to claim 6, Features: The bioactive molecules include cell adhesion factors and growth factors, and the neurotrophic factors include nerve growth factor and brain-derived neurotrophic factor.

8. The stem cell-based nerve damage repair technology according to claim 5, Features: Molecules with immunomodulatory functions, including transforming growth factor, are introduced into the scaffold to regulate local immune responses and reduce the rejection reaction between the three-dimensional scaffold and human cells. Microspheres or nanoparticles are prepared using biodegradable polymers, which encapsulate transforming growth factor and mix it into the scaffold material.

9. The stem cell-based nerve damage repair technology according to claim 1, Features: In step S4, the implantation of neurotrophic factors can utilize biomaterials as carriers to control the release rate of neurotrophic factors so that they can be released stably and for a long time. The neurotrophic factors are encapsulated in hydrogels and gradually released after being implanted in the target area.

10. A stem cell-based nerve damage repair technology according to claim 9, Features: Neurotrophic factors encapsulated in hydrogels can be implanted near the affected area while the three-dimensional scaffold is implanted in the affected area. The pore structure of the hydrogel has an important influence on the release rate of the neurotrophic factors. By controlling the pore size and distribution of the hydrogel, the diffusion rate and release rate of the neurotrophic factors can be adjusted. Larger pores will lead to faster release rates, while smaller pores will slow down the release rate.